tiprankstipranks
IRLAB Therapeutics AB Class A (DE:6IRA)
FRANKFURT:6IRA
6IRA
IRLAB Therapeutics AB Class A
RESEARCH TOOLSreports

Compare IRLAB Therapeutics AB Class A (6IRA) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
6IRA
IRLAB Therapeutics AB Class A
€0.18
€12.19M
-1.72
-77.98%
―
xxxxxxxxxxxxx
6IRA
xxxxxxxxxxxxx
ISOFOL
Isofol Medical AB
kr0.72
kr193.12M
-2.92
-55.79%
―
xxxxxxxxxxxxx
6IRA vs ISOFOL
xxxxxxxxxxxxx
XINT
Xintela AB
kr0.28
kr244.60M
-4.03
-25.46%
―
xxxxxxxxxxxxx
6IRA vs XINT
xxxxxxxxxxxxx
ELIC
Elicera Therapeutics AB
kr5.35
kr274.23M
-13.67
91.20%
―
xxxxxxxxxxxxx
6IRA vs ELIC
xxxxxxxxxxxxx
ACTI
Active Biotech AB
kr0.04
kr160.80M
-1.70
10.91%
―
xxxxxxxxxxxxx
6IRA vs ACTI
xxxxxxxxxxxxx
INIT
Initiator Pharma A/S
kr3.04
kr223.84M
-9.08
-44.76%
―
xxxxxxxxxxxxx
6IRA vs INIT
xxxxxxxxxxxxx

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:6IRA
IRLAB Therapeutics AB Class A
0.13
-0.49
-78.48%
SE:ISOFOL
Isofol Medical AB
0.69
-0.87
-55.79%
SE:XINT
Xintela AB
0.28
-0.09
-23.24%
SE:ELIC
Elicera Therapeutics AB
5.65
2.40
73.85%
SE:ACTI
Active Biotech AB
0.06
<0.01
8.93%
SE:INIT
Initiator Pharma A/S
3.27
-3.01
-47.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
Compare More Stocks >